» Articles » PMID: 837968

Fluorometric Determination of Hydroflumethiazide in Human Plasma and Urine After Its Oral Administration

Overview
Specialty Pharmacology
Date 1977 Jan 3
PMID 837968
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

A spectrofluorometric method for determination of hydroflumethiazide in human plasma and urine has been developed. The limit of detection was 10 ng/ml plasma and 100 ng/ml urine. The plasma concentration of hydroflumethiazide was determined for 9-11 hours and excretion in urine for 24-37 hrs after oral administration of about 1 mg/kg body weight to 7 subjects. Plasma half life in healthy subjects was 1.9-2.1 h, and 2.7-8.6 h in patients during the period 4-9 hrs after dosing. Cumulative excretion in urine was 67-79% of the dose during 31-37 hrs in 6 subjects; one patient with renal disease was found to excrete only 25.8% of dose during 24 hours. Renal clearance of hydroflumethiazide was higher in the healthy subjects (0.29-0.44 1 h-1 kg-1) than in the patients (0.040-0.15 1 h-1 kg-1). Plasma half life of hydroflumethiazide was not closely correlated with renal clearance of the drug, which suggests that other factors may play a role in determining plasma half life.

Citing Articles

A fluorimetric assay for metolazone in urine.

Vose C, Stevens P, Muirhead D, Palmer R, McInnes G Br J Clin Pharmacol. 1980; 9(2):213-5.

PMID: 7356909 PMC: 1429855. DOI: 10.1111/j.1365-2125.1980.tb05836.x.


Clinical pharmacokinetics of diuretics.

BEERMANN B Clin Pharmacokinet. 1980; 5(3):221-45.

PMID: 6993083 DOI: 10.2165/00003088-198005030-00003.


Pharmacokinetics of a single oral dose of hydroflumethiazide in health and in cardiac failure.-.

Brors O, Jacobsen S, Arnesen E Eur J Clin Pharmacol. 1978; 14(1):29-37.

PMID: 729604 DOI: 10.1007/BF00560255.


Distribution of elimination of hydroflumethiazide in man.

Brors O, Jacobsen S Eur J Clin Pharmacol. 1979; 16(2):125-31.

PMID: 499309 DOI: 10.1007/BF00563119.


Excretion of hydroflumethiazide in bile and urine of man.

Brors O, Haffner J, Jacobsen S Eur J Clin Pharmacol. 1979; 15(4):287-9.

PMID: 477714 DOI: 10.1007/BF00618519.


References
1.
ROEDIGER P, Alden J, BEARDWOOD D, HUTCHISON J . BENZOTHIADIAXINES AND DIABETES MELLITUS. II. COMPARISON OF HYPERGLYCEMIC EFFECTS OF BENDROFLUMETHIAZIDE AND CHLOROTHIAZIDE IN HYPERTENSIVE PATIENTS WITH DIABETES MELLITUS. Curr Ther Res Clin Exp. 1964; 6:670-6. View

2.
Blagg C . Hydroflumethiazide: a new oral diuretic. Lancet. 1959; 2(7098):311-3. DOI: 10.1016/s0140-6736(59)91356-x. View

3.
TAPIA F . Diuretic and antihypertensive effects of polythiazide. Curr Ther Res Clin Exp. 1961; 3:365-77. View

4.
HEIMSOTH V, Hartmann F . [Studies on uric acid metabolism disorders following administration of saluretics]. Dtsch Med Wochenschr. 1965; 90(43):1905-8. DOI: 10.1055/s-0028-1113442. View

5.
Young D, FORRESTER T, Morgan T . A comparison of the diuretic action of the chlorothiazide analogues. Lancet. 1959; 2(7106):765-8. DOI: 10.1016/s0140-6736(59)90861-x. View